Valuing preferences for treating screen detected ductal carcinoma in situ
Hannah L Bromley, G Bruce Mann, Dennis Petrie, Carolyn Nickson, Daniel Rea, Tracy E Roberts
European Journal of Cancer | ELSEVIER SCI LTD | Published : 2019
BACKGROUND: Mammographic screening reduces breast cancer mortality but may lead to the overdiagnosis and overtreatment of low-risk breast cancers. Conservative management may reduce the potential harm of overtreatment, yet little is known about the impact upon quality of life. OBJECTIVES: To quantify women's preferences for managing low-risk screen detected ductal carcinoma in situ (DCIS), including the acceptability of active monitoring as an alternative treatment. METHODS: Utilities (cardinal measures of quality of life) were elicited from 172 women using visual analogue scales (VASs), standard gambles, and the Euro-Qol-5D-5L questionnaire for seven health states describing treatments for ..View full abstract
This study was funded by a Melbourne International Research Scholarship as part of a Universitas 21 PhD Scholarship between the Universities of Melbourne and Birmingham.